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Abstract 1 
Objectives: Infections, cancer and systemic inflammation elicit anorexia. Despite the 2 
medical significance of this phenomenon, the question of how peripheral inflammatory 3 
mediators affect the central regulation of food intake is incompletely understood. Therefore, 4 
we have investigated the sickness behavior induced by the prototypical inflammatory 5 
mediator IL-1β.  6 
Methods: IL-1β was injected intravenously. To interfere with IL-1β signaling we deleted the 7 
essential modulator of NF-κB signaling (Nemo) in astrocytes and tanycytes. 8 
Results: Systemic IL-1β increased the activity of the transcription factor NF-κB in tanycytes 9 
of the mediobasal hypothalamus (MBH). By activating NF-κB signaling, IL-1β induced the 10 
expression of cyclooxygenase-2 (Cox-2) and stimulated the release of the anorexigenic 11 
prostaglandin E2 (PGE2) from tanycytes. When we deleted Nemo in astrocytes and 12 
tanycytes, the IL-1β-induced anorexia was alleviated whereas the fever and lethargy 13 
response were unchanged. Similar results were obtained after selective deletion of Nemo 14 
exclusively in tanycytes.  15 
Conclusions: Tanycytes form the brain barrier that mediates the anorexic effect of systemic 16 
inflammation in the hypothalamus. 17 
Key words  18 
Tanycytes, inflammation-induced anorexia, IL-1β, NEMO  19 
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1. Introduction 1 
Cachexia and anorexia in chronic diseases, like HIV infection or cancer, worsen the outcome 2 
and increase mortality [1-3].  A prominent mechanism underlying cachexia is thought to be 3 
systemic inflammation [4]. Inflammation induces the so-called sickness response including 4 
fever, lethargy, and anorexia. This repertoire of physiological reactions is conserved during 5 
evolution, and, in another context, seems to have a physiological benefit. Apparently, it helps 6 
mobilize the resources required to combat specific causal pathogens [5]. Infection-induced 7 
anorexia increases the host tolerance to bacterial inflammation [6]. In turn, pathogens have 8 
developed means to manipulate the host response. Salmonella typhimurium modulates host 9 
survival and promotes disease transmission to other subjects by interfering with the 10 
maturation of IL-1β that induces anorexia [7].  11 
Pro-inflammatory cytokines such as IL-1β are essential for the host response to inflammation 12 
and infection. In accordance with this notion, IL-1β is induced by local or systemic 13 
inflammation and, when administered systemically, triggers many of the characteristic 14 
physiological changes, including anorexia, fever and lethargy [8]. Upon binding to its 15 
membrane receptor IL-1R1 that is widely expressed in the CNS [9], IL-1β stimulates a pro-16 
inflammatory signaling cascade that is mediated by the adaptor protein Myd88. In line with 17 
this, global deletion of Myd88 prevented inflammation-induced anorexia [10; 11]. 18 
Downstream of Myd88, IL-1β activates the canonical NF-κB signaling pathway that involves 19 
the protein kinase IKK complex. The latter consists of two enzymatic subunits and the 20 
essential regulatory subunit NEMO. Among the hundreds of NF-κB target genes, Ptgs2 (Cox-21 
2) stands out in the context of inflammation-induced anorexia because blocking its activity by 22 
common analgesic and antipyretic drugs, such as acetylsalicylic acid or celecoxib, reduces 23 
fever and inflammation-induced anorexia [12; 13]. Thus, a precise picture of the molecular 24 
signaling pathways that mediate inflammation-induced anorexia emerges, but less is known 25 
about which cellular and anatomic routes convey the inflammatory signal to the hypothalamic 26 
centers that regulate food intake. With a molecular weight of about 17 kD, IL-1β is too big for 27 
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unassisted diffusion through brain barriers, although there are some reports that small 1 
amounts of radioactively labeled IL-1β can enter the brain [14].  Endothelial cells of the 2 
blood-brain barrier are a key hub for transmitting fever inducing signals into the 3 
hypothalamus [15-18]. In marked contrast, endothelial cells do not mediate anorexia that is 4 
induced by peripheral inflammation [17; 19; 20].  5 
In the MHB, tanycytes represent another barrier forming cell type [21]. These specialized 6 
glial cells separate the vascular compartment and circumventricular organs from brain 7 
parenchyma and cerebrospinal fluid (CSF). They line the wall and floor of the 3rd ventricle in 8 
the MHB and project into the ventromedial nucleus (VMH) and arcuate nucleus (ARC), the 9 
hypothalamic centers that regulate appetite [21]. A link to metabolic regulation is further 10 
suggested by the observation that tanycytes are able to sense glucose [22] and ghrelin [23] 11 
and to transport leptin into the CNS [24]. However, their physiological function in regulating 12 
food intake still remains largely elusive. 13 
In this study we have investigated the cellular pathways mediating IL-1β-induced anorexia. 14 
Systemic IL-1β administration stimulated NF-κB activity in tanycytes of the MHB. To inhibit 15 
NF-κB signaling we deleted the essential IKK subunit NEMO in glial cells and tanycytes 16 
demonstrating that IL-1β-induced anorexia at least partially depends on tanycytic NF-κB 17 
signaling. These data suggest tanycytes as an important route to transfer peripheral immune 18 
signals into the CNS and modulate the energy supply under inflammatory conditions. 19 
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2. Materials and methods 1 
2.1. Animals  2 
Animal experiments were approved by the local ethic committee (Ministerium für 3 
Energiewende, Landwirtschaft, Umwelt, Natur und Digitalisierung in Kiel, Germany; Animal 4 
Care and Use Committee at Linköping University, Sweden) and were in accordance with the 5 
EU Directive 2010/63/EU for animal experiments. For all experiments we used male 8-12-6 
weeks old mice that were on a C57Bl/6 background. They were housed on a light-dark cycle 7 
of 12 h and at a temperature of 22°C, except for body temperature measurements, which 8 
were performed under near thermo-neutral conditions (29°C). All mice had ad-libitum access 9 
to a standard laboratory diet (2.98 kcal/g; Altromin, Hannover, Germany; 2.91 kcal/g, 10 
Lantmännen, Malmö, Sweden) and water, unless indicated otherwise. To investigate the 11 
influence of NF-κB in tanycytes under pro-inflammatory conditions, NemoFL mice [25] were 12 
crossed with mice which express a tamoxifen-inducible Cre recombinase under the glia-13 
specific Glast promoter (GlastCreERT2) [26]. At an age of 8-10 weeks, tamoxifen was injected 14 
(1 mg, every 12 h over 5 days) to induce Nemo knockout in glial cells (NemogliaKO). 15 
Tamoxifen-treated Cre-negative littermates were used as controls (NemoFL). NF-κB reporter 16 
mice (κ-EGFP) [27] and Il1r1GR/GR reporter mice [28] have been described previously. To 17 
specifically delete Nemo in tanycytes a rAAV approach was used that we have recently 18 
developed [29]. We tested the cell specificity of AAV-Dio2-iCre-2A-EGFP and GlastCreERT2 19 
with the Cre reporter mouse line Ai14 [30]. All mice were randomly allocated to treatment 20 
groups. Investigators were blinded for treatment or genotype of mice or both whenever 21 
possible. Mice were only excluded from analysis if they did not survive during surgical 22 
procedures or if samples could not be obtained.  23 
2.2. Primary tanycyte cell culture 24 
Tanycytes were isolated from P10 Sprague Dawley rats (Janvier) by dissecting the wall of 25 
the 3rd ventricle of the MBH as described previously [31]. A tanycyte cell culture contained 26 
tissue from 20 pups, which had been collected in culture medium (DMEM high-glucose 27 
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medium containing 10% fetal calf serum, 1% penicillin/streptomycin, and 2 mM L-glutamine, 1 
Thermo Fisher) on ice. To separate tanycytes, samples were scraped through a nylon mesh 2 
(20 µm, Merck Millipore), centrifuged and cells were resuspended in fresh culture medium. 3 
No medium change was done within the first 10 days, afterwards medium was changed twice 4 
a week. Cultures that reached confluency were split by trypsin/ETDA digestion and plated in 5 
6-well plates for further experiments. After 3 weeks the medium of the cultures was changed 6 
to starvation medium (DMEM/F12 without phenol red, 1% penicillin/streptomycin and 2 mM 7 
L-glutamine, all from Thermo Fisher). One h before the experiment started, cells were 8 
changed to experimental medium (DMEM/F12 without phenol red, 1% 9 
penicillin/streptomycin, 2 mM L-glutamine (all from Thermo Fisher) and 0.15% insulin and 10 
0.3% putrescine (last two from Sigma-Aldrich, USA)) and treated with rat recombinant IL-1β 11 
(0.25 µg/ml, Peprotech) or PBS. Cells were harvested after 0, 2, 4, 8 and 24 h by washing 12 
them 3 times with ice-cold PBS and shock freeze on dry ice. The purity of the primary cell 13 
culture was confirmed by immunostaining of vimentin, GFAP, and CD11b as well as by qRT-14 
PCR.  15 
To inhibit NF-κB, tanycytes were treated prior to the experiment with 25 µM BMS-345541 16 
(dissolved in DMSO, Axon Medchem BV) or 0.25% DMSO. After 30 min cells were treated 17 
with rat recombinant IL-1β (0.25 µg/ml, Peprotech). The supernatant was collected after 2 18 
and 8 h of treatment and the cells were harvested. Secreted prostaglandin E2 was measured 19 
by using the Prostaglandin E2 Elisa kit (Cayman) according to the manufacturer’s 20 
instructions. 21 
2.3. AAV production and stereotaxic vector injections 22 
AAV with a mosaic capsid of serotype 1 and 2 (1:1) were generated as described and 23 
purified by AVB Sepharose affinity chromatography [29]. For each vector, the genomic titer 24 
was determined by quantitative PCR (qPCR) using primers against WPRE (WPRE forward 25 
primer: 5’-TGC CCG CTG CTG GAC-3’; WPRE reverse primer: 5’-CCG ACA ACA CCA 26 
CGG AAT TG-3’) as described previously [29]. For stereotaxic injections, NemoFL mice were 27 
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anesthetized with ketamine (65 µg/g, KetavetTM, Pfizer) and xylazine (14 µg/g, RompunTM, 1 
Bayer) before they were fixed in the stereotaxic frame (David Kopf Instruments). During the 2 
procedure the body temperature was maintained at 37°C by a heating plate. After drilling a 3 
small borehole between bregma and lambda, AAV vectors (1011 genomic particles in 2 µl) 4 
were injected into the lateral ventricle (anteroposterior −0.1 mm, mediolateral −0.9 mm, 5 
dorsoventral from the skull surface −2.3 mm relative to bregma) as described previously [29]. 6 
Injections were performed over 5 min and the cannula stayed in place for another 10 min to 7 
avoid backflow of the vectors. The scalp was sutured and the animals were treated with 8 
carprofen (5 mg/kg; s.c.) for 2 days. NemoFL mice received either AAV-Dio2-Cre-2A-EGFP to 9 
express the Cre recombinase under the tanycytic specific Dio2 promoter (NemotanKO) or the 10 
control vector AAV-Dio2-EGFP without Cre activity (NemoCon).  11 
2.4. IL-1β effects on feeding and related parameters 12 
Mice received PBS and, after a lag time of 2 days, recombinant mouse IL-1β (20 µg/kg, i.v., 13 
Peprotech). Both treatments were administered by injection into the tail vein under 14 
anesthesia (4% isoflurane) one h before lights turned off. At the same time, the food was 15 
removed and returned at beginning of the dark phase. Food and water intake as well as body 16 
weight, respiratory exchange ratio (RER) and energy expenditure (EE) were monitored over 17 
24 h by indirect calorimetry.  18 
2.5. Measurement of cytokine concentrations in plasma  19 
For measuring cytokine concentrations in plasma, NemoFL and NemogliaKO mice were treated 20 
with IL-1β (20 µg/kg, i.v., Peprotech) and were sacrificed after 4, 8 and 24 h by a lethal dose 21 
of pentobarbital (150 µg/g, i.p.). Blood samples were obtained by heart puncture in EDTA 22 
vials (Sarstedt). IL-1β, IL-6, and TNF were measured in plasma by MILLIPLEX mouse kit 23 
(Merck Millipore) according to the manufacturer’s instructions. 24 
2.6. Reporter mice for monitoring NF-κB activation and Il1r1 expression  25 
κ-EGFP mice were used to identify cells with NF-κB activity in the MBH after IL-1β treatment. 26 
Therefore, κ-EGFP mice were treated either with mouse recombinant IL-1β (20 µg/kg, i.v.) or 27 
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with PBS under 4% isoflurane anesthesia. Eight h later mice were sacrificed by a lethal dose 1 
of pentobarbital (150 µg/g, i.p.). Brains were post-fixed in paraformaldehyde (PFA, 4%), 2 
cryoprotected by incubation in sucrose (30% in PBS) for 24 h and stored at -80°C. We 3 
counted EGFP-positive cell bodies. 4 
To localize Il1r1 expression we used Il1r1GR/GR mice [28]. To enhance IL-1R1 expression, the 5 
animals were treated with LPS (120 µg/kg, E. coli serotype 0111:B4, i.p.) and perfused after 6 
6 h with 0.9% saline at room temperature, followed by ice-cold PFA (4%, pH 9.5). Brains 7 
were post-fixed for 2 h and cryoprotected for 48 h.  8 
2.7. Telemetric monitoring of mice 9 
Two weeks after inducing recombination with tamoxifen, mice were anesthetized with 10 
isoflurane and transmitters (TA-F10, Data Science International) were intraperitoneally 11 
implanted. For postoperative pain management we administered carprofen (5 mg/kg, s.c.) 12 
every 12 h for 2 days. Seven days after implanting transmitters, mice were treated with IL-1β 13 
(20 µg/kg, i.v.) 3 h after lights-on and the body temperature and activity were monitored. 14 
Novelty stress was evaluated during animal care. After NemoFL and NemogliaKO mice carrying 15 
telemetric transmitters were transferred to new cages during the inactive light phase, body 16 
temperature and activity were recorded. 17 
2.8. Indirect calorimetry 18 
For indirect calorimetry 3 weeks after tamoxifen (NemoFL and NemogliaKO) or virus injection 19 
(Nemocon and NemotanKO), mice were kept in ventilated cages of the PhenoMaster System 20 
(TSE, Germany) for 7 days on a 12 h light/dark cycle at 23°C. After 3 days of adaption PBS 21 
and two days later IL-1β (20 µg/kg, i.v.) were intravenously injected 1 h before lights turned 22 
off according to the same protocol as described above. Food and water intake were 23 
automatically monitored every 30 min. O2 and CO2 concentrations in the cages were 24 
measured every 30 min to determine EE and RER. All measurements ran simultaneously. 25 
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EE was calculated as 3.941 x O2 consumed [l] + 1.106 x CO2 produced [l]. The measurements after 1 
PBS treatment served as intra-individual controls for the IL-1β treatment.   2 
2.9. Isolation of tanycytes and RT-PCR 3 
For laser microdissection, native coronal cryosections (25-µm thick) of the MBH were 4 
mounted on membrane slides 1.0 PEN (Zeiss, Germany). Tanycytes were microdissected 5 
using the Axiovert 200 M microscope (Zeiss, Germany) and a system with a pulsed 337-nm 6 
UV laser (PALM MicroBeam, PALM Microlaser Technologies) and the laser-pressure 7 
catapulting mode. Areas corresponding to α-tanycytes (about 10,000 μm²) and to the ARC 8 
(about 60,000 μm²) were dissected on 8 sections of the MBH (bregma −1.58 mm to −1.7 9 
mm) and pooled. RNA was isolated using the Absolutely RNA Nanoprep Kit (Agilent 10 
Technologies) according to the manufacturer’s instructions. RNA was transcribed into cDNA 11 
by the reverse transcriptase AMV (Avian Myeloblastosis Virus; Cloned AMV First-Strand 12 
cDNA Synthesis Kit, Invitrogen) with oligo(dT) primers and diluted 1:1 in diethyl 13 
pyrocarbonate (DEPC) water (Sigma Aldrich). For real-time PCR the following primers were 14 
used: Ptgs2 forward primer 5’- CTG ACC CCC AAG GCT CAA AT -3’, Ptgs2 reverse primer 15 
5’- AAG TCC ACT CCA TGG CCC AG -3’, PCR product 124 bp; Agrp forward primer 5’-16 
CGC TTC TTC AAT GCC TTT TGC-3’, Agrp reverse primer 5’-ATT CTC ATC CCC TGC 17 
CTT TGC-3’, PCR product 108 bp; Npy forward primer 5’-TCG CTC TAT CTC TGC TCG 18 
TGT G-3’, Npy reverse primer 5’-AGT ATC TGG CCA TGT CCT CTG C-3’, PCR product 19 
105 bp; Pomc forward primer 5’-AGC GTT ACG GTG GCT TCA TGA-3’; Pomc reverse 20 
primer 5’-TGG AAT GAG AAG ACC CCT GCA-3’, PCR product 125 bp; and Gapdh forward 21 
primer 5’-CCT ACC CCC AAT GTA TCC GTT-3’, Gapdh reverse primer 5’-TAG CCC AGG 22 
ATG CCC TTT AGT-3’, PCR product 122 bp. Real-time PCR was performed with the 23 
Platinium SYBR Green qPCR Super Mix (Invitrogen) according to the following protocol: 2 24 
min at 50 °C, 2 min at 95 °C, 15 s at 95 °C, and 1 min at 60 °C (40 cycles). Quantified results 25 
were normalized to Gapdh using the ΔΔCt method. 26 
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From primary rat tanycytes RNA was extracted with the help of NucleoSpin columns 1 
(Macherey-Nagel). For quantification of gene expression the following primers were used: 2 
Ptgs2 forward primer  5’-CTC AGC CAT GCA GCA AAT CC-3’, Ptgs2 reverse primer 5’-3 
GGG TGG GCT TCA GCA GTA AT-3’, PCR product 172 bp; Il1b forward primer 5’-GGC 4 
TTC CTT GTG CAA GTG TC-3’, Il1b reverse primer 5’-CCC AAG TCA AGG GCT TGG AA-5 
3’, PCR product 152 bp; Il1r1 forward primer 5’-TGT GGC TGA AGA GCA CAG AG-3’, Il1r1 6 
reverse primer 5’-TGG ATC CTG GGT CAG CTT C-3’, PCR product 172 bp; Vcam1 forward 7 
primer 5’-GGA AAT GCC ACC CTC ACC TT-3’, Vcam1 reverse primer 5’-AAC AGT AAA 8 
TGG TTT CTC TTG AAC A-3’, PCR product 132 bp; and Gapdh forward primer 5’-CCT ACC 9 
CCC AAT GTA TCC GTT-3’, Gapdh reverse primer 5’-TAG CCC AGG ATG CCC TTT AGT-10 
3’, PCR product 122 bp.  11 
For FACS-sorting of tanycytes we used a protocol reported previously [32]. Briefly, tanycytes 12 
were labeled by injecting the Tat-Cre fusion protein in the third ventricle of Ai14 reporter 13 
mice. Then, Tomato-positive tanycytes and Tomato-negative other cells were sorted. RNA 14 
obtained from FACS-sorted cells was reverse transcribed using the High-Capacity cDNA 15 
Reverse Transcription Kit (4374966, Life Technologies) and a linear pre-amplification step 16 
was performed using TaqMan PreAmp Master Mix (4488593, Life Technologies). Real-time 17 
PCR was carried out on Applied Biosystems 7900 HT Fast Real-Time PCR System using the 18 
following exon-boundary-specific TaqMan Gene Expression Assays (Applied Biosystems): 19 
Il1r1, Mm00434237_m1; Il1b, Mm00434228_m1; Ikbkg, Mm00494927_m1; Nfkb1, 20 
Mm00476361_m1; Ptgs2,  Mm00478374_m1; Vcam1, Mm01320970_m1; Vimentin, 21 
Mm01333430_m1; Darpp32 (Ppp1r1b), Mm00454892_m1; Gpr50, Mm00439147_m1; Gfap, 22 
Mm01253033_m1; Npy, Mm03048253_m1; Pomc, Mm00435874_m1; r18S, 23 
Mm03928990_g1; Actb, Mm00607939. Gene expression data were analyzed using SDS 24 
2.4.1 and DataAssist 3.0.1 software (Applied Biosystem). 25 
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2.10. Western blotting 1 
Primary tanycytes were lysed with 1% cell lysis buffer (Cell Signaling) supplemented with 2 
phenylmethylsulfonyl fluorid (PMSF, 0.5 M Sigma-Aldrich). Protein concentrations in the 3 
lysates were measured with the Lowry assay. After SDS-PAGE proteins were transferred to 4 
nitrocellulose membranes that were incubated with primary antibodies against COX-2 (1:250, 5 
sc-1747, Santa Cruz) and GAPDH (1:2,500, ab9485, Abcam) at 4°C overnight followed by 6 
incubation with secondary antibodies (1:2,500 HRP-labeled anti-goat IgG, DakoCytomation, 7 
Denmark; 1:5,000 HRP-labeled anti-rabbit IgG, Santa Cruz) at room temperature for 1 h. 8 
Detection was achieved by chemiluminescence (SuperSignal West Femto Substrate, 9 
Thermo Scientific) and a digital detection system (Fusion Solo S, VWR International). 10 
2.11. Immunohistochemistry 11 
To visualize NF-κB activation, serial coronal cryosections (25-μm thick) of NF-κB reporter 12 
mice (κ-EGFP) in the area of the ME (bregma −1.35 to −2.46 mm) were processed for 13 
immunohistochemistry. First, PFA-fixed sections were washed twice with Tris buffered saline 14 
(TBS; Tris 50 mM; NaCl, 150 mM; pH 7.6) for 5 min at room temperature, incubated in TBS 15 
containing 0.3% Triton-X100 (TBST, Promega) for 15 min for permeabilisation, and then in 16 
TBST containing 5% BSA (Sigma-Aldrich) for 30 min at room temperature. Subsequently, 17 
samples were incubated overnight at 4°C with primary antibodies: anti-GFP, 1:500 (ab13970, 18 
Abcam); anti-vimentin, 1:500 (5741, New England Biolabs); anti-GFAP, 1:500 (Z033429-2, 19 
Dako); anti-Iba1, 1:500 (019-19741, Wako); and anti-collagen-IV 1:1,000, (Abcam #ab6586). 20 
Finally, sections were incubated with secondary antibodies: Alexa 488-labeled goat anti-21 
chicken, 1:5,000 (Abcam); CyTM3-conjugated donkey anti-rabbit, 1:1,000 22 
(Jackson/Dianova), and Dapi (1 µg/ml, Sigma-Aldrich) for 1 h at room temperature.  23 
Frozen cryosections of NemoFL and NemoglialKO mice were fixed in methanol for 10 min at -24 
20°C, washed three times with PBS and incubated in PBS containing 1% BSA for 45 min at 25 
room temperature. Subsequently, primary antibodies were added: anti-VCAM1, 1:1,000 26 
(550547, BD-Pharmingen) overnight at 4°C. Then, sections were washed with PBS three 27 
times before incubation with secondary antibodies: Alexa 488-labled anti-rat IgG, 1:1,000 (A-28 
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21208, Invitrogen) for 45 min at room temperature. Finally, sections were covered using 1 
Mowiol and a coverslip. Pictures were taken with the confocal microscope SP5 (Leica) and 2 
10x or 20x objectives. For quantification of VCAM1, the mean grey value of an area of 458 3 
mm2 was determined with ImageJ software (National Institutes of Health). All sections were 4 
stained in parallel and measured with the same settings.  5 
For detecting the reporter tdTomato in Il1r1GR/GR mice, 30-µm free-floating sections were 6 
incubated overnight in rabbit anti-RFP, 1:1,000 (Abcam) in PBS containing 2% normal 7 
donkey serum and 0.3% Triton X-100. Then, sections were incubated for 2 h at room 8 
temperature in secondary antibodies: Alexa 555-labeled donkey anti-rabbit IgG, 1:1,000 (Life 9 
Technologies).  10 
To analyze the specificity of the AAV-based targeting of tanycytes, Ai14 mice were perfused 11 
with 4% PFA two weeks after injecting AAV-Dio2-Cre-2A-EGFP (5x1010 genomic particles) 12 
into the lateral ventricle. To investigate recombination specificity in GlastCreERT2 mice, we 13 
treated GlastCreERT2::Ai14 mice with tamoxifen. Brains were postfixed in 4% PFA at 4°C 14 
overnight. For staining free-floating sections (50 µm) were washed twice in TBS, 15 
permeabilized in TBST for 30 min, and incubated in TBST containing 5% BSA for 2 h. Then, 16 
sections were incubated in primary antibodies: anti-GFAP, 1:500, (Z033429-2, Dako); anti-17 
CD11b, 1:500 (557397, BD Pharmingen); anti-ppTRH, 1:2,000 (a gift of Martin Wessendorf); 18 
and NeuN, 1:500, (MAB377, Millipore) overnight and in Alexa 488-labeled anti-rabbit IgG 19 
(1:500, Invitrogen #A-21206) or anti-mouse IgG (1:400, A-31619, Invitrogen) for 2 h. They 20 
were mounted as described above. 21 
For COX-2 staining, mice were perfused with a solution containing 2% PFA and 0.2% 22 
glutaraldehyde. For antigen retrieval, vibratome sections (50-μm thick) of the MBH were 23 
incubated in sodium citrate buffer (10 mM, pH 6, 85°C) for 30 min followed by H2O2 treatment 24 
(1%, 30 min). After blocking with BSA (5% in PBS + 0.3% Triton-X100) for 2 h, samples were 25 
incubated overnight at 4°C with anti-COX-2 (M17-R, Santa Cruz, 1:1,000). Then, biotinylated 26 
secondary antibodies against rabbit IgG (1:250, Vector, BR1000) were added for 2 h. For 27 
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detection we used DAB amplification (A/B Kit, Vector; DAB-Kit, Vector). All sections were 1 
stained in parallel and incubated for 1.5 min in the DAB + nickel solution.   2 
2.12. In situ hybridization for Nemo mRNA 3 
The in situ hybridization for Nemo mRNA was performed with the RNAscope® Multiplex 4 
Fluorescent Reagent Kit v2 (Advanced Cell Diagnostics, ACD, Hayward, CA, USA). We used 5 
a set of 20 double Z probes targeting the first 6 exons of Nemo (nucleotides 246-1135 in 6 
NM_001136067) which include exon 2 that is floxed in NemoFL animals [25]. Briefly, 20-μm 7 
mouse brain cryosections were post-fixed at room temperature in freshly prepared 4% PFA 8 
for 15 min, dehydrated with ethanol, backed for 30 min at 37°C, and treated with hydrogen 9 
peroxide and protease IV. Then, the sections were incubated with double Z probes for 2 h at 10 
40°C, and hybridized sequentially by preamplifiers, amplifiers, HRP-labeled oligonucleotides, 11 
followed by TSA® Plus Cyanine 3 probe. Nuclei were counterstained with Dapi. We mounted 12 
sections with fluoromount (ACD). After in situ hybridization, the sections were imaged with 13 
the confocal microscope Leica TCS SP5. Scoring of the Nemo mRNA signal in the tanycyte 14 
layer of the 3rd ventricle was performed according to the manufacturer’s scoring guideline 15 
(ACD). The Nemo mRNA signal scoring was done as follows: score 1 if 1-3 dots/cell, score 2 16 
in 4-9 dots/cell [33]. In at least 4 sections per animal the Nemo+ cells were counted in the 17 
tanycytic layer.  A blinding strategy was followed while scoring the RNAscope images.  18 
2.13. Statistical analysis 19 
All data are presented as means ± standard error of the mean (SEM). For statistical 20 
comparison of two groups we used the Mann Whitney test, unless the sample size per group 21 
was bigger than 9 and values were normally distributed. In this case, t-test was applied. For 22 
more than two groups the analysis was performed by one-way ANOVA with subsequent 23 
Bonferroni post-hoc test or Friedman test. Time-dependent data were analyzed with two-way 24 
repeated measures ANOVA followed by Bonferroni post-hoc test. A p value < 0.05 was 25 
considered statistically significant. G-Power (Version 3.1.8) was used to analyze power and 26 
group size for the experiments.  27 
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3. Results  1 
3.1. IL-1β directly stimulates NF-κB activity in tanycytes in vivo 2 
To determine in which cells of the MBH systemic IL-1β induces NF-κB activity, we injected 3 
IL-1β (20 µg/kg, i.v.) into NF-κB-EGFP reporter (κ-EGFP) mice, expressing the enhanced 4 
green fluorescent protein (EGFP) under the control of an artificial NF-κB promoter [27]. After 5 
IL-1β administration, EGFP expression was pronounced in vimentin-positive tanycytes 6 
projecting mainly in the VMH (α1-tanycytes) and few tanycytes projecting into the 7 
ventromedial ARC (vmARC, dorsal β1-tanycytes, Figure 1, A and B) but not in tanycytes 8 
projecting to the capillary bed of the median eminence (ME, ventral β1- and β2-tanycytes 9 
Figure 1, A and C) or the dorsomedial ARC (α2-tanycytes). Counting of EGFP+ tanycytes 10 
revealed a significant increase after IL-1β injection in comparison to the PBS treated control 11 
group (Figure 1D). Additional EGFP expression was detectable in Iba1-positive microglia and 12 
blood vessels. Only few GFAP-positive astrocytes in the ME were positive for EGFP 13 
(Supplementary Figure 1).  14 
Since we had observed that systemic IL-1β stimulates NF-κB activity in tanycytes, we 15 
wondered whether IL-1β is able to directly act on tanycytes. Using in situ hybridization, a 16 
previous study reported a low mRNA signal for Il1r1, the essential IL-1 receptor, in the 17 
tanycytic layer [34]. However, in situ hybridization may not be sensitive enough for the 18 
detection of all functionally relevant Il1r1 expression, as less than 10 IL-1R1 molecules per 19 
cell are sufficient to mediate an effect of IL-1β [35]. In tanycytes that were sorted from the 20 
MBH of mice we detected mRNA of various components of the IL-1 signaling pathway, 21 
including Il1r1, at similar levels as in non-tanycytic cells (Figure 1 E, Supplementary Figure 22 
2). Using Il1r1 reporter mice (Il1r1GR/GR) [28], in which the Il1r1 locus drives expression of the 23 
reporter tdTomato, we confirmed Il1r1 expression by detecting tdTomato-positive cells in the 24 
wall of the 3rd ventricle that projected into VMH and DMH, corresponding to the main 25 
localization of NF-κB activity in α1-tanycytes after IL-1β stimulation (Figure 1F). These cells 26 
had the typical tanycytic cell shape (Figure 1G). 27 
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IL-1β is known to upregulate COX-2 in endothelial cells of the BBB [36]. To test whether IL-1 
1β also induces COX-2 in tanycytes, we stained sections 8 h after vehicle and IL-1β injection. 2 
As reported previously, COX-2 was found in cells of the hippocampus and in endothelial cells 3 
of IL-1β-treated animals with a perinuclear distribution [36; 37] corroborating the specificity of 4 
the staining. Interestingly, IL-1β treatment led to a weak but distinct staining of cells in the 5 
tanycytic layer (Fig. 1, H and I). 6 
3.2. Tanycytes express pro-inflammatory genes after IL-1β stimulation  7 
In line with the notion that tanycytes are sensitive to IL-1β, we also detected Il1r1 mRNA in 8 
cultured primary tanycytes by RT-PCR (Figure 2A). Interestingly, IL-1β (0.25 µg/ml) 9 
enhanced its own expression, which is controlled by NF-κB (Figure 2B), as well as the NF-κB 10 
target gene vascular cell adhesion molecule 1 (Vcam1) (Figure 2C).  In accordance with the 11 
in vivo findings (Fig. 1, H and I), IL-1β treatment induced the mRNA levels of the immediate 12 
early gene Ptgs2 encoding COX-2 already after 2 h (Figure 2D). At the protein level COX-2 13 
was significantly up-regulated with a more prolonged time course (Figure 2, E and F).  14 
To test whether IL-1β enhances COX-2 levels through NF-κB-dependent signaling, primary 15 
tanycytes were treated with the IKK specific inhibitor BMS-345541 [38, 25 µM] 30 min before 16 
adding IL-1β (0.25 µg/ml). BMS-345541 almost completely suppressed COX-2 induction by 17 
IL-1β in primary tanycytes (Figure 2, G and H) confirming that NF-κB signaling mediates the 18 
effect of IL-1β. Tanycytes are able to release prostaglandins, such as PGE2 [31; 39-41]. To 19 
address the functional relevance of COX-2 in tanycytes, we measured PGE2 in the 20 
supernatant. IL-1β stimulated PGE2 release and BMS-345541 blocked the stimulation by IL-21 
1β (Figure 2I). In summary, the data demonstrate that tanycytes respond to IL-1β stimulation 22 
by activating NF-κB signaling, up-regulating Ptgs2 as well as other target genes, and 23 
releasing prostanoids which can cause direct effects in the hypothalamus. 24 
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3.3. Glial Nemo knockout reduces NF-κB target genes in α-tanycytes 1 
After having observed that IL-1β activates NF-κB in tanycytes, we aimed to interrupt NF-κB 2 
signaling in a cell-specific manner. IL-1β stimulates NF-κB through the canonical signaling 3 
pathway that crucially depends on NEMO [42]. To delete Nemo we crossed NemoFL  mice 4 
[25] and the GlastCreERT2  line that allows for selective gene deletion in astrocytes and 5 
tanycytes but not in microglia or neurons (Supplementary Fig. 3)[26; 29; 43], resulting in 6 
NemogliaKO mice. First, we investigated the expression of the validated NF-κB target gene 7 
VCAM1 by immunohistochemistry (Figure 3, A-J). Previous studies showed that VCAM1 is 8 
up-regulated in the blood-brain barrier and choroid plexus during inflammation and is 9 
involved in transmitting inflammatory signals across brain barriers [44-46]. Injecting IL-1β (20 10 
µg/kg, i.v.) to κ-EGFP mice increased VCAM1 staining in vimentin-positive α-tanycytes in 11 
which also NF-κB was activated (Supplementary Figure 4). Upon IL-1β treatment, VCAM1 12 
levels were lower in NemogliaKO than in NemoFL mice (Figure 3, A-J), in accordance with the 13 
notion that the Nemo deletion interfered with NF-κB signaling in tanycytes. In addition, we 14 
isolated the responsive α-tanycytes, β2-tanycytes and cells in the ARC by laser capture 15 
microdissection (LCM, Figure 3K) to quantify mRNA expression of Nemo and NF-κB target 16 
genes by RT-PCR. In NemogliaKO mice, Nemo was deleted in tanycytes, confirming the 17 
efficiency of the genetic intervention (Figure 3L). After IL-1β injection, α-tanycytes expressed 18 
lower levels of Ptgs2 mRNA in NemogliaKO mice than in NemoFL controls (Figure 3M), while in 19 
ARC samples the Ptgs2 mRNA expression did not significantly differ between the genotypes 20 
(Figure 3N). Another NF-κB target gene is the anorexigenic Pomc that is expressed in rat 21 
tanycytes [47]. In parallel to the Ptgs2 mRNA expression, we observed a trend towards lower 22 
mRNA level of Pomc in tanycytes of NemogliaKO mice after IL-1β-treatment in comparison to 23 
NemoFL controls (Figure 3O). Hence, the glia and tanycyte specific deletion of Nemo 24 
interfered with the induction of NF-κB target genes Vcam1, Ptgs2, and possibly Pomc that 25 
may serve tanycytes to conduct inflammatory signals into the ARC and other hypothalamic 26 
centers. 27 
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To address the possibility that NemoFL and NemogliaKO mice could differ in the systemic 1 
inflammatory response to IL-1β, we measured cytokine plasma concentrations of IL-1β, IL-6 2 
and TNF after IL-1β administration. TNF plasma concentrations did not rise above the 3 
detection limit of 20 pg/ml (data not shown). IL-1β and IL-6 plasma concentrations were 4 
elevated 4 h after IL-1β injection and decreased over time, independently of the genotype 5 
(Figure 3, P and Q). These findings suggest that IL-1β administration leads to a similar 6 
inflammatory stimulus in the peripheral compartment of NemoFL and NemogliaKO mice. 7 
3.4. IL-1β-induced anorexia depends on glial NEMO  8 
To determine whether deletion of Nemo in glial cells leads to a metabolic phenotype under 9 
basal conditions we evaluated the body weight under tamoxifen treatment, and  body weight, 10 
feeding efficiency, food and water intake, as well as EE and RER using indirect calorimetry, 3 11 
weeks after induction of the knockout (Supplementary Figure 5, A-G). These parameters did 12 
not differ between NemogliaKO and NemoFL control mice. To investigate whether glial NEMO 13 
mediates the metabolic effects of IL-1β, we intravenously administered first PBS and after 14 
two days IL-1β (20 µg/kg) to the same animals 1 h before their active phase. In accordance 15 
with the literature, IL-1β induced anorexia in NemoFL mice but this effect was blunted in 16 
NemogliaKO littermates with inhibited NF-κB signaling in astrocytes and tanycytes (Figure 4A). 17 
During the first 9 h after IL-1β administration, NemoFL mice were severely anorexic and 18 
consumed less than 0.5 g food, whereas food ingestion was more than doubled in NemogliaKO 19 
mice (Figure 4B). At later time points during the inactive phase, food intake did not differ 20 
between the groups (data not shown). Therefore, we also analyzed the other metabolic 21 
parameters in the active phase within the first 9 h after IL-1β treatment. In parallel to food 22 
intake, water consumption was diminished by IL-1β in comparison to PBS treatment (Figure 23 
4C). NemogliaKO mice only showed a trend towards more water intake than NemoFL 24 
littermates. Changes in food intake were reflected by the RER. As the ratio between the 25 
amount of CO2 produced and O2 consumed in metabolism, the RER is close to 1 when 26 
carbohydrates serve as energy source during feeding but it drops to about 0.7 during fasting 27 
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when fat metabolism meets the energy demand [48]. IL-1β reduced the RER in NemoFL 1 
controls in parallel to the lower food intake (Figure 4D). In contrast, glial NF-κB inhibition in 2 
NemogliaKO mice led to an almost normal RER confirming that anorexia was ameliorated 3 
(Figure 4D). In addition, IL-1β treatment diminished EE in NemoFL mice but not in NemogliaKO 4 
animals, although the difference between genotypes missed statistical significance (Figure 5 
4E). Due to the lower food intake after IL-1β treatment, NemoFL mice showed a loss of body 6 
weight 9 h after IL-1β injection which was mitigated in NemogliaKO animals (Figure 4F). As a 7 
potential explanation of the increased food intake, NemogliaKO mice had higher mRNA levels 8 
of the orexigenic gene Agrp in LCM-dissected samples of the ARC than NemoFL controls 9 
after IL-1β treatment (Figure 4G), while Pomc and Npy mRNA expression did not differ in the 10 
ARC (Figure 4, H and I). These data demonstrate that glial NEMO downregulates Agrp 11 
expression in the ARC and partially mediates the IL-1β-induced anorexia.  12 
3.5. Fever and lethargy are not affected by glial Nemo knockout 13 
To evaluate the role of glial NEMO in fever and lethargy, we determined body temperature 14 
and spontaneous home cage locomotion by telemetry. In untreated mice body temperature 15 
and locomotion showed a circadian rhythm and did not differ between the NemoFL and 16 
NemogliaKO genotypes (Supplementary Figure 6, A and B). Also when we subjected the mice 17 
to novelty stress, the transient rise in body temperature and locomotion due to the new 18 
environment was not affected by the genotype (Supplementary Figure 6, C and D). 19 
Injecting IL-1β or PBS led to a transient rise in body temperature in the first h (Figure 4J). 20 
However, after 90 min body temperature returned to baseline levels in PBS-treated NemoFL 21 
mice, while IL-1β significantly increased body temperature in NemogliaKO and NemoFL mice 22 
(Figure 4J). Importantly, the second IL-1β-induced rise in body temperature was not different 23 
in NemogliaKO mice compared with NemoFL controls. If anything, the body temperature was 24 
higher in NemogliaKO than in NemoFL mice 60 – 150 min after IL-1β administration but this 25 
difference did not reach statistical significance (Figure 4J). In parallel, the cumulative activity 26 
during the first 9 h after injection decreased in response to IL-1β and again did not differ 27 
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between NemoFL and NemogliaKO mice (Figure 4K). These data show that glial NEMO is 1 
required for IL-1β-induced anorexia but not for fever and lethargy.  2 
3.6. Tanycytes mediate the IL-1β-induced anorexic effect 3 
The experiments in the κ-EGFP reporter mice (Figure 1, A-D) and the NF-κB-dependent 4 
expression of VCAM1 (Figure 3, A-J) suggested that systemic IL-1β activates hypothalamic 5 
NF-κB selectively in tanycytes. To investigate whether deleting Nemo only in tanycytes 6 
suffices to protect animals from IL-1β-induced anorexia, we used a technique to target 7 
tanycytes that we have recently described [29]. The approach is based on the combination of 8 
local i.c.v. administration of AAV1/2 vectors that get trapped in the ventricle wall and 9 
transduce only few parenchymal cells and on the tanycyte-specific promoter Dio2. Injecting 10 
the vector AAV-Dio2-Cre-2A-EGFP into Ai14 reporter mice, in which tdTomato is a reporter 11 
of Cre activity, we confirmed the selectivity for tanycytes (Figure 5A). Four weeks after 12 
treating NemoFL animals with AAV-Dio2-Cre-2A-EGFP (NemotanKO) to induce recombination 13 
in tanycytes or with AAV-Dio2-EGFP as control vector (NemoCon), we assessed Nemo 14 
deletion by detecting Nemo mRNA on sections with in situ hybridization. Although the in situ 15 
probe partially hybridizes to the transcript derived from the recombined gene (see Methods 16 
section), we found a significant downregulation of the tanycytic Nemo signal in NemotanKO 17 
mice by 33% (Figure 5, B and C). NemotanKO mice showed no difference in body weight, food 18 
and water intake, EE as well as RER under basal conditions (Supplementary Figure 7, A-E), 19 
similar to NemogliaKO mice (Supplementary Figure 5). Also after receiving PBS, NemoCon and 20 
NemotanKO mice did not differ in food intake (Figure 5, D and E). The subsequent treatment 21 
with IL-1β (20 µg/kg, i.v.) decreased food consumption of NemoFL controls as seen before. 22 
However, the IL-1β-induced anorexia was mitigated in NemotanKO mice, in which NF-κB 23 
signaling was inhibited in tanycytes (Figure 5, D and E). In parallel, water intake was lower 24 
after IL-1β treatment but did not differ between the genotypes (Figure 5F). The deletion of 25 
Nemo in tanycytes ameliorated the RER reduction after IL-1β treatment, in accordance with 26 
the higher food intake (Figure 5G). However, IL-1β treatment reduced EE to a similar extent 27 
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in NemoCon and NemotanKO mice (Figure 5H). In these experiments, the body weight loss due 1 
to IL-1β was mitigated by the Nemo deletion in tanycytes (Figure 5I). Overall, the data 2 
indicate that NF-κB signaling in tanycytes mediates the anorexic effect of IL-1β.  3 
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4. Discussion 1 
Anorexia is an evolutionarily conserved adaptive response to inflammation and seems to 2 
promote the defense against pathogens. In chronic inflammation, this mechanism can go 3 
awry and cause life-threatening cachexia. So far, the underlying cellular mechanisms were 4 
still unclear. Our study now demonstrates a significant involvement of glial cells in the 5 
inflammation-induced anorexia mediated by the NF-κB signaling pathway.  Astrocytes [49; 6 
50] and, as shown by the present study, tanycytes are responsive to IL-1β. However, after 7 
systemic administration IL-1β activated NF-κB only in few astrocytes of the ME 8 
(Supplementary Figure 1). More prominent was the activation of NF-κB in tanycytes, 9 
microvessels and microglia. Importantly, the tanycyte-specific deletion of Nemo was 10 
sufficient to interfere with IL-1β-induced anorexia. Therefore, we conclude that NF-κB 11 
signaling in tanycytes mediates inflammation-induced anorexia, at least partially. In contrast, 12 
NF-κB signaling in astrocytes has been reported to promote obesity [51-53].  13 
Anorexia adds to the growing list of vital physiological functions that are mediated by 14 
tanycytes in the MBH [21]. On the one hand, tanycytes control neurosecretion of the 15 
hypothalamic releasing hormones GnRH and TRH [29; 54]. On the other hand, they sense 16 
peripheral signals, such as leptin, glucose, and IL-1β according to this study, and transmit 17 
the message to neuroendocrine and metabolic centers in the hypothalamus [24; 55]. As a 18 
common denominator, tanycytes seem to serve as a switchboard between the periphery and 19 
the hypothalamus. They are able to carry out this task due to their location at the interface 20 
between blood and CSF or brain parenchyma. From there, they send projections to essential 21 
nuclei in the MBH. As shown in this study, tanycytes projecting in the VMH and ARC respond 22 
to IL-1β and mediate the anorexigenic effect of systemic IL-1β. We suggest that the open 23 
blood-brain barrier in the circumventricular areas allows IL-1β to leave the vessel lumen, to 24 
act on tanycytes and to stimulate NF-κB signaling. Fenestrated endothelial cells of the ME 25 
and the pars tuberalis or other cell types may amplify the pro-inflammatory signal [56] or 26 
actively transport IL-1β into the CSF [14; 57]. IL-1β may also induce its own synthesis in the 27 
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hypothalamus [58]. In addition to IL-1β, systemically administered LPS activates NF-κB in 1 
tanycytes [59] and induces anorexia. As the anorexic effect of peripheral LPS does not 2 
depend on IL1R1 [60], LPS likely acts directly on tanycytes to induce a similar cascade of 3 
events as IL-1β.  4 
The role of tanycytes in transmitting inflammatory signals from the periphery to the 5 
hypothalamus seems to be specifically focused on anorexia, because tanycytic NF-κB did 6 
not modulate fever and lethargy. In contrast, endothelial NF-κB mediates IL-1β-induced fever 7 
and lethargy but not food intake [17]. Thus, independent mechanisms underlie the various 8 
facets of the sickness response [17; 60; 61]. These findings also illustrate that anorexia does 9 
not simply reflect an unspecific secondary effect of general sickness but rather an 10 
independent effect of systemic inflammation. 11 
NF-κB signaling in tanycytes emerges as an attractive target to ameliorate cachexia and to 12 
reduce mortality in cancer and chronic infections. Since inhibiting NF-κB is an effective 13 
treatment strategy to stop tumor progression [62], blockers of NF-κB signaling may provide 14 
dual benefit for patients with malignant diseases. Alternative targets for treating cachexia are 15 
IL-1 itself or COX-2 as a downstream gene of NF-κB in tanycytes. Clinical trials and 16 
experimental studies show that an anti-IL-1 antibody and COX-2 inhibitors improve anorexia 17 
in infections, cancer cachexia, and systemic inflammation [12; 13; 63-65]. The early phase of 18 
anorexia is mediated by COX-1, while COX-2 seems to maintain anorexia [13]. Interestingly, 19 
this time course is also reflected in our results. After IL-1β treatment, both NemogliaKO and 20 
NemotanKO mice started to eat again earlier than control animals, indicating a predominant 21 
effect of the tanycytic COX-2 expression in the later phase of anorexia. Supporting the 22 
relevance of tanycytes, cell-specific knockouts of COX-2 in endothelia, neurons and myeloid 23 
cells failed to inhibit LPS-induced anorexia [19]. The localization of tanycytes in the ventricle 24 
wall may explain why prostaglandin levels are elevated in the CSF during inflammation [60; 25 
66]. When injected into the ventricle, PGE2 or PGF2α have an anorexic effect [67; 68]. 26 
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However, the specific prostaglandin downstream of COX-2 that mediates anorexia differs 1 
between species and even mouse strains [65; 69-71].  2 
Parallel to the NF-κB–COX-2–prostaglandin pathway, there are several other potential 3 
mechanisms how tanycytes could mediate anorexia. A candidate is the anorexic 4 
gliotransmitter ACBP that is expressed in tanycytes, despite the observation that deletion of 5 
ACBP in tanycytes does not affect food intake and body weight on a high-fat diet [72]. In 6 
accordance with previous work, we detected Pomc mRNA in tanycytes [47]. Pomc showed a 7 
trend towards lower expression in tanycytes of NemogliaKO mice after systemic IL-1β 8 
treatment. Regulation of Pomc expression by NF-κB in neurons of the ARC seems to be 9 
functionally relevant because deletion of the β subunit of IKK in POMC-positive cells reduced 10 
inflammation-induced anorexia [73]. After translation, POMC is cleaved to the active and 11 
anorectic peptide α-MSH, which was detected in low concentrations in tanycytes of rats [47]. 12 
An IL-1β-dependent release of α-MSH by tanycytes could mediate the direct anorexic effect 13 
of inflammation.  14 
Tanycytes are able to modulate the expression of orexigenic and anorexigenic peptides in 15 
the hypothalamus and thereby food intake [74]. IL-1β-treated NemogliaKO mice had a higher 16 
expression of Agrp mRNA in the ARC compared with NemoFL mice. AGRP likely enhances 17 
food intake after IL-1β administration, since the parallel injection of AGRP into the CSF 18 
abolished anorexia induced by IL-1β [75]. If the release of α-MSH by tanycytes contributes to 19 
the IL-1β-induced anorexia, upregulation of AGRP could inhibit the α-MSH effects, since 20 
AGRP is a direct antagonist of α-MSH [76]. AGRP neurons also project into the bed nucleus 21 
of stria terminalis (BNST), which is an important nucleus for feeding behavior [77]. Upon 22 
stimulation, AGRP neurons release GABA and, by inhibiting PKC-δ neurons in the oval part 23 
of the BNST, increase food intake under IL-1β and LPS treatment [77; 78].  24 
The physiological importance of the central response to inflammation suggests that, in 25 
addition to the tanycytic pathway, other mechanisms may contribute to anorexia. Such a 26 
scenario would explain why the IL-1β-mediated anorexia was only partly rescued by tanycytic 27 
NEMO deficiency (Figure 4, Figure 5). The vagus nerve expresses IL-1R1 and can deliver 28 
  
24 
 
pro-inflammatory signals from the periphery to the brainstem [79-81]. Vagal afferents end in 1 
the nucleus of the solitary tract that is connected to the parabrachial nucleus containing an 2 
‘emergency circuit’ that mediates cancer-induced anorexia [82; 83].  3 
5. Conclusions 4 
This study has identified a tanycytic cell population, which directly senses peripheral IL-1β. 5 
Triggered by systemic inflammation, tanycytes mount an NF-κB response, express COX-2, 6 
release prostaglandins and modulate orexigenic and anorexigenic peptides in the 7 
hypothalamus. Inhibition of the NF-κB pathway in tanycytes mitigated anorexia in vivo. 8 
Overall, tanycytes emerge as an important mediator of inflammation-induced anorexia.  9 
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FIGURE LEGENDS 1 
Figure 1: Systemic IL-1β activates NF-κB in tanycytes.  2 
(A) Representative immunostainings of the mediobasal hypothalamus (MBH) of κ-EGFP reporter mice 3 
8 h after IL-1β (20 µg/kg, i.v.) or PBS injection. EGFP (A, white; B and C, cyan) reflecting NF-κB 4 
activity (cell bodies, arrow; projections, arrowheads) of tanycytes (vimentin, magenta). Asterisks 5 
indicate EGFP+ microglia. Scale bar, 100 µm. (B, C) Higher magnification of boxed area in A (green 6 
box, B; yellow box, C). Scale bar, 20 µm. (D) Number of EGFP+ tanycytes in the MBH per section. 7 
Means ± SEM *p<0.01 (Mann-Whitney test, n=3 sections/mouse of 3 mice/group). (E) mRNA 8 
expression of various genes of the IL-1β signaling pathway in FACS-sorted tanycytes (red, tdTomato-9 
positive) and non-tanycytic cells (gray, tdTomato-negative). Medians ± quartiles. (F, G) tdTomato 10 
immunostainings (white) in tanycytes of Il1r1GR/GR mice indicating Il1r1 transcription. Staining was 11 
performed 6 h after LPS treatment (120 µg/kg, i.p.). Yellow arrowheads indicate contact points of 12 
tanycytic endings and blood vessels. Scale bar, 150 µm (F) and 20 µm (G). (H, I) Representative 13 
COX-2 immunostainings 8 h after i.v. injection of NaCl (H) or IL-1β (20 µg/kg, I). In the hippocampus 14 
positive cells could be identified after NaCl injection. After IL-1β treatment, COX-2-positive cells were 15 
detectable in the tanycytic layer and bigger blood vessels (I). Arrowheads, COX-2-positive cell bodies; 16 
yellow box, magnified field; scale bar, 100 µm (hypothalamic overview), 50 µm (vessels, 17 
hippocampus), 10 µm (magnified field). 18 
Figure 2: IL-1β stimulates the release of PGE2 from tanycytes by activating the NF-κB pathway. 19 
(A) After treating primary tanycytes with IL-1β (0.25 µg/ml) or PBS for 24 h, Il1r1 (172 bp) and Gapdh 20 
(122 bp) mRNA were detected by RT-PCR (representative images of the agarose gels). (B-D) 21 
Expression of Il1b (B), Vcam1 (C) and Ptgs2 (D) over time after IL-1β stimulation of primary tanycytes. 22 
Two-way ANOVA for treatment: Il1b, F(1,20)=21.33, p=0.0002; Vcam1, F(1,20)=12.09, p=0.0024; Ptgs2, 23 
F(1,19)=6.11, p=0.023. *p<0.05, **p<0.01, ***p<0.001 (Bonferroni post-test, n=3 independent primary 24 
cell cultures of 3 wells/experiment). (E, F) Western blots of COX-2 after IL-1β (0.25 µg/ml) stimulation 25 
of primary tanyctes. GAPDH served as a loading control. Quantification of COX-2 protein levels at 26 
various time points after IL-1β stimulation (F). Two-way ANOVA for treatment, F(1,20)=41.57, p<0.0001. 27 
(Bonferroni post test, n=3 independent primary cell cultures of 3 wells/experiment). (G, H) 28 
Pretreatment with the IKK inhibitor BMS-345541 (BMS, 25 µM) blocked the induction of COX-2 by IL-29 
1β (0.25 µg/ml) in primary tanycytes. Quantification of COX-2 protein levels (H). Two-way ANOVA; 30 
Bonferroni post test, n=2 independent primary cell cultures of 3 wells/experiment. (I) Quantification of 31 
PGE2 levels in the medium showed that IL-1β stimulated PGE2 secretion in an IKK-dependent 32 
manner. For IL-1β treatment: F(1,14)= 8.745, p=0.0104; for BMS treatment, F(1,14)=15.48, p=0.0015; 33 
interaction, F(1,14)=14.08, p=0.0021, post-test: *p=0.017 (Two-way ANOVA; Bonferroni post-test, n=3 34 
independent primary cell cultures of 3 wells/experiment). 35 
Figure 3: Glial deletion of Nemo (NemogliaKO) interferes with the induction of NF-κB target genes 36 
by IL-1β.  37 
(A-I) Immunohistochemistry showed that IL-1β (20 µg/kg, i.v.) up-regulated the NF-κB target gene 38 
VCAM1 in α-tanycytes of NemoFL but not of NemogliaKO mice. Representative immunostainings of 39 
VCAM1 in coronal mediobasal hypothalamus (MBH) sections of NemoFL (A-C) and NemogliaKO (D-F) 40 
mice 8 h after IL-1β treatment and PBS treated NemoFL mice (G-I). (B), (C), (E), (F) and (H), (I) are 41 
higher magnifications of the boxed areas in (A), (D) and (G), respectively. Scale bar, 100 µm. (J) 42 
Quantification of VCAM1 staining in α-tanycytes projecting mainly into the VMH at various time points 43 
after IL-1β administration. Values are means ± SEM. Two-way ANOVA for genotype, F(1, 29)=4.46, 44 
p=0.044. *p<0.05 (Bonferroni post-test, n=7-8 animals per group). (K) Nissl-stained coronal section of 45 
the MBH showing microdissected areas of the tanycytic layer and arcuate nucleus (ARC). ME, median 46 
eminence; 3V, 3rd ventricle; scale bar, 100 µm. (L) Representative agarose gels after RT-PCR for 47 
Nemo and β-actin in microdissected tanycytes from NemoFL and NemogliaKO mice. (M, N) Ptgs2 mRNA 48 
was reduced in tanycytes of NemogliaKO mice in comparison to NemoFL controls 4 h after IL-1β 49 
treatment (M). In contrast, there was no difference in the ARC (N).  *p<0.05 (Mann-Whitney test, n=6-8 50 
mice/group). (O) Pomc mRNA was reduced in tanycytes of NemogliaKO mice in comparison to NemoFL 51 
controls 4 h after IL-1β treatment (Mann-Whitney test, n=6-8 mice/group). (P, Q) Plasma 52 
concentrations of IL-6 (M) and IL-1β (N) did not differ between NemoFL and NemogliaKO animals after 53 
intravenous IL-1β injection. Values are means ± SEM (n=6-8 mice/group). 54 
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Figure 4: Glial deletion of Nemo (NemogliaKO) mitigates IL-1β-induced anorexia but has no effect 1 
on body temperature and locomotor activity.  2 
(A) The IL-1β-induced anorexia was mitigated by glial deletion of Nemo. NemoFL (blue) and NemogliaKO 3 
mice (purple) were treated with PBS and two days later with IL-1β (20 µg/kg, i.v., 1 h before start of 4 
the active phase). Cumulative food intake is shown. (B-D) Food ingestion (B), water intake (C), and 5 
the respiratory exchange ratio (RER, D) of NemoFL and NemogliaKO mice over 9 h after IL-1β or PBS 6 
treatment. Means ± SEM. Repeated-measures ANOVA for the interaction between treatment and 7 
genotype; F(1,20)=5.56, p=0.029 (B); F(1,20)=4.82, p=0.04 (D). *p<0.05; **p<0.01 (Bonferroni post-test); 8 
ns, non-significant. (E) The reduction in energy expenditure by IL-1β (ΔEE) showed a trend towards 9 
normalization in NemogliaKO mice in comparison to NemoFL controls. Means ± SEM (t-test, n=10-12 10 
mice/group). (F) Loss of body weight of NemogliaKO and NemoFL mice 9 h after IL-1β administration. 11 
**p<0.01 (Mann Whitney test, n=5-6 mice/group). (G) Agrp mRNA levels in the ARC were higher in 12 
NemogliaKO mice than in NemoFL controls 4 h after IL-1β injection. **p<0.01 (Mann Whitney test, n=6 13 
mice/group). (H, I) Expression of Pomc mRNA (H) and Npy mRNA (I) in ARC were unchanged in 14 
NemogliaKO mice compared with NemoFL controls 4 h after IL-1β injection (Mann-Whitney test, n=6 15 
mice/group). (J) After a lag time of about 60 min, IL-1β (i.v., 20 µg/kg) increased the body temperature 16 
of NemoFL and NemogliaKO mice in comparison to PBS-treated conditions. There was a trend towards 17 
higher body temperatures in NemogliaKO than in NemoFL mice after IL-1β treatment. Repeated-18 
measures ANOVA for genotype, F(1,2304)=4.35, p=0.052. ns, non-significant (Bonferroni post-test). (K) 19 
In parallel, IL-1β treatment but not genotype reduced locomotor activity. One-way ANOVA, F(2,38)=6.56, 20 
p=0.0037. *p<0.05, **p<0.01, ns, non-significant (Bonferroni post-test, n=9-19 mice/group).  21 
Figure 5: Tanycytic deletion of Nemo increases food intake after IL-1β treatment.  22 
(A) Injecting AAV-Dio2-Cre-2A-EGFP into the ventricle of Ai14 mice led to selective expression of the 23 
Cre reporter tdTomato (weight / red) in tanycytes. Blue, Dapi; scale bar, 100 µm. (B) Nemo mRNA 24 
(red) in the tanycyte layer. Representative in situ hybridization is shown. Tanycyte-specific Nemo 25 
knockout mice (NemotanKO) were generated by injecting AAV-Dio2-Cre-2A-EGFP in the lateral ventricle 26 
of NemoFL mice. NemoFL mice that received control AAV-Dio2-EGFP are called Nemocon.  Gray, Dapi; 27 
scale bar, 1 µm. (C) Numbers of Nemo-positive cells in tanycytic layer as determined by in situ 28 
hybridization. *p<0.05 (t-test). Values are means ± SEM. (D) IL-1β-induced anorexia was alleviated in 29 
NemotanKO mice in comparison to NemoFL controls. Four weeks after virus injection, mice were treated 30 
with PBS and two days later with IL-1β (20 µg/kg). Cumulative food intake at various time points after 31 
IL-1β treatment is shown. Values are means ± SEM (n=7-11 mice/group). (E-G) Food ingestion (E), 32 
water intake (F), and the respiratory exchange ratio (RER, G) of Nemocon and NemotanKO mice during a 33 
period of 6 h after IL-1β or PBS treatment are depicted. Means ± SEM and individual values are 34 
shown. Repeated-measures ANOVA for interaction of treatment and genotype; F(1,15)=4.26, p=0.057 35 
(E); F(1,15)=7.69, p=0.014 (G). *p<0.05 (Bonferroni post-test). (H) The reduction in energy expenditure 36 
by IL-1β (ΔEE) was similar in NemotanKO mice and in Nemocon controls. Values are means ± SEM (t-37 
test, n=8-10 mice/group). (I) Body weight loss 6 h after IL-1β administration was reduced in NemotanKO 38 
mice. *p<0.05 (Mann-Whitney test, n=8-9 mice/group). 39 
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Highlights 
• Systemic IL-1β activates NF-κB in tanycytes. 
• IL-1β induces the expression of Ptgs2 (Cox-2) and the release of PGE2 from 
tanycytes. 
• NEMO-dependent NF-κB signaling in tanycytes is required for the anorexia induced 
by IL-1β. 
• Tanycytes are not involved in fever and lethargy induced by IL-1β. 
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